Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Outsmarting SARS-CoV-2 by empowering a decoy ACE2 | Signal Transduction and Targeted Therapy
Targeting ACE2 as a treatment for COVID | LGC Standards
SARS-CoV-2 receptor |Human ACE2-Fc | InvivoGen
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
ACE2 - The SARS-CoV-2 Receptor | Biomol Blog | Resources | Biomol GmbH - Life Science Shop
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Receptors for SARS-CoV-2 Present in Wide Variety of Human Cells | The Scientist Magazine®
Oral Mucosa Shows High Expression of ACE2 Receptor of 2019-nCoV | PracticeUpdate
Frontiers | SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) | Journal of Clinical Pathology
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2 - Kidney International
DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging | EMBO reports
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell - ScienceDirect
IJMS | Free Full-Text | Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
ACE2: Targeting a Potentially Important Receptor in Disease Pathogenesis | CAS
.jpg "ACE2 homology in laboratory and wild animals")
ACE2 homology in laboratory and wild animals
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | SpringerLink
